1h Free Analyst Time
The stem cell therapy market is forecasted to grow by USD 16.67 billion during 2023-2028, accelerating at a CAGR of 18.69% during the forecast period. The report on the stem cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in awareness of stem cell therapy, and rising regulatory approval for drug development.
The stem cell therapy market is segmented as below:
By Application
- Cancer
- Musculoskeletal disorder
- Cardiovascular disease
- Others
By Type
- Allogeneic transplants
- Autologous transplants
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the stem cell therapy market covers the following areas:
- Stem cell therapy market sizing
- Stem cell therapy market forecast
- Stem cell therapy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global stem cell therapy market: Athersys Inc., Becton Dickinson and Co., Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., CRISPR Therapeutics AG, Cynata Therapeutics Ltd., Cytori Therapeutics Inc., FUJIFILM Corp., Gamida Cell Ltd., Johnson and Johnson Services Inc., Lonza Group Ltd., Mesoblast Ltd., Novartis AG, Pfizer Inc., Pluri Inc., ReNeuron Group plc, STEMCELL Technologies Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vericel Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise in costs of stem cell transplantation."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Athersys Inc.
- Becton Dickinson and Co.
- Brainstorm Cell Therapeutics Inc.
- Bristol Myers Squibb Co.
- CRISPR Therapeutics AG
- Cynata Therapeutics Ltd.
- Cytori Therapeutics Inc.
- FUJIFILM Corp.
- Gamida Cell Ltd.
- Johnson and Johnson Services Inc.
- Lonza Group Ltd.
- Mesoblast Ltd.
- Novartis AG
- Pfizer Inc.
- Pluri Inc.
- ReNeuron Group plc
- STEMCELL Technologies Inc.
- Takeda Pharmaceutical Co. Ltd.
- Thermo Fisher Scientific Inc.
- Vericel Corp.
